[Nonspecific mesenchymal reactions and parenchymal damages in the liver of patients with Hodgkin's disease].
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000368:Aged; D000469:Alkaline Phosphatase / Q000097:blood; D001663:Bilirubin / Q000097:blood; D001798:Blood Proteins / Q000032:analysis; D002779:Cholestasis / Q000209:etiology; D005223:Fats / Q000032:analysis; D005234:Fatty Liver / Q000209:etiology; D005260:Female; D006689:Hodgkin Disease / Q000097:blood / Q000150:complications* / Q000188:drug therapy / Q000201:enzymology / Q000378:metabolism; D006801:Humans; D008099:Liver / Q000032:analysis; D008107:Liver Diseases / Q000209:etiology*; D008112:Liver Glycogen / Q000032:analysis; D008297:Male; D008875:Middle Aged; D011241:Prednisone / Q000627:therapeutic use; D012737:Sex Factors; D000637:Transaminases / Q000097:blood
D001798:Blood Proteins; D005223:Fats; D008112:Liver Glycogen; D000637:Transaminases; D000469:Alkaline Phosphatase; D001663:Bilirubin; D011241:Prednisone
Unspezifische Mesenchymreaktionen und Parenchymschäden der Leber bei Patienten mit Morbus Hodgkin.